Students at Lewis Katz School of Medicine stand to benefit from new $1 million NIGMS grant
Rapid evolution in the field of biomedical research demands well-trained scientists. Adapting biomedical research training programs to keep up with the increasingly complex and interdisciplinary nature of the field, however, presents complex challenges for higher-education institutions.
The Lewis Katz School of Medicine at Temple University, home to highly skilled researchers and professors and known for its collaborative atmosphere, has long been on the cutting edge of biomedical research. Now, PhD and MD/PhD students in the Biomedical Sciences Graduate Program at Temple stand to benefit even further from these in-house resources, gaining unprecedented opportunities to learn from researchers across multiple departments, thanks to a new $1 million T32 predoctoral training grant from the National Institute of General Medical Sciences (NIGMS) within the National Institutes of Health (NIH).
Gerald R (Jerry) Mattys Joins Pelvital USA, Inc Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Everspring and Yeshiva University Expand Fully Digital Experience to MBA Program
Innovation and engagement are at the core of the successful online learning platform
News provided by
Share this article
Share this article
NEW YORK, May 11, 2021 /PRNewswire/ Everspring Inc., a leading provider of education technology and services to universities seeking to build or expand their online capabilities, announced today it has significantly expanded its relationship with Yeshiva University to include the Sy Syms School of Business. The expansion includes taking the highly respected Sy Syms MBA program fully digital.
Sy Syms is the fourth school at Yeshiva to entrust its digital presence to Everspring. The other partner schools include the Wurzweiler School of Social Work, the Benjamin N. Cardozo School of Law, and the Katz School of Science and Health.
Novel CBD analog alleviates pain in mouse model of chemotherapy-induced peripheral neuropathy
For patients with chronic pain, ineffective treatments, lowered work productivity, and other factors often coalesce, fueling feelings of hopelessness and anxiety and setting the stage for even bigger problems, including substance use disorders. In 2017 alone, some 18 million Americans misused prescription pain relievers over the course of the previous year. In many of these instances, patients suffering from chronic pain became addicted to prescription opioids.
In addition to being highly addictive, many studies suggest that prescription opioids do not effectively control pain over the long term, and hence researchers have been exploring various alternatives, including cannabidiol (CBD). CBD is a non-psychoactive substance derived from the Cannabis plant.
E-Mail
IMAGE: Sara Jane Ward, PhD, Assistant Professor of Pharmacology at the Lewis Katz School of Medicine at Temple University. view more
Credit: Temple University Health System
(Philadelphia, PA) - For patients with chronic pain, ineffective treatments, lowered work productivity, and other factors often coalesce, fueling feelings of hopelessness and anxiety and setting the stage for even bigger problems, including substance use disorders. In 2017 alone, some 18 million Americans misused prescription pain relievers over the course of the previous year. In many of these instances, patients suffering from chronic pain became addicted to prescription opioids.
In addition to being highly addictive, many studies suggest that prescription opioids do not effectively control pain over the long term, and hence researchers have been exploring various alternatives, including cannabidiol (CBD). CBD is a non-psychoactive substance derived from the Cannabis plant.
vimarsana © 2020. All Rights Reserved.